Ladan Fazlollahi
Overview
Explore the profile of Ladan Fazlollahi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
794
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen T, Satwani P, Kumar D, Kapoor U, Malik S, Prince C, et al.
J Allergy Clin Immunol
. 2024 Sep;
155(1):199-212.
PMID: 39278359
Background: Severe hepatitis cases in children are increasingly recognized, but the exact etiology remains unknown in a significant proportion of patients. Cases of indeterminate severe hepatitis (iSH) may progress to...
2.
Wu L, Jang S, Shapiro C, Fazlollahi L, Wang T, Ryeom S, et al.
Target Oncol
. 2024 Sep;
19(6):845-865.
PMID: 39271577
Diffuse-type gastric cancer (DGC) accounts for approximately one-third of gastric cancer diagnoses but is a more clinically aggressive disease with peritoneal metastases and inferior survival compared with intestinal-type gastric cancer...
3.
Manukyan I, Hsiao S, Fazlollahi L, Remotti H, Mansukhani M
Hum Pathol
. 2024 Jun;
150():36-41.
PMID: 38914167
Intraductal tubulopapillary neoplasms (ITPNs) are rare pancreatic tumors with distinct histological and molecular features. Distinction of ITPN from other pancreatic neoplasms is crucial given the known favorable prognosis and the...
4.
Desai N, Kudose S, Remotti H, Del Portillo A, Fazlollahi L, Lee M, et al.
Virchows Arch
. 2023 Nov;
484(1):61-69.
PMID: 37924345
Hemophagocytic lymphohistiocytosis (HLH) is a rare disease with high mortality. Liver involvement is common (based on elevated liver function tests) with most patients demonstrating acute hepatitis. Liver biopsies are frequently...
5.
Jiang N, Sewell T, Kowalski T, Rekab A, Hills S, Fazlollahi L, et al.
Am J Med Genet A
. 2023 Oct;
194(2):389-393.
PMID: 37850634
We report a novel homozygous 49.6 kb deletion of chromosome 18q12.1 involving the last exon of DSG3 in dizygotic twins with phenotype consistent with acantholytic blistering of the oral and...
6.
Saito Y, Yin D, Kubota N, Wang X, Filliol A, Remotti H, et al.
Gastroenterology
. 2023 Mar;
164(7):1279-1292.
PMID: 36894036
Background & Aims: Despite recent progress, long-term survival remains low for hepatocellular carcinoma (HCC). The most effective HCC therapies target the tumor immune microenvironment (TIME), and there are almost no...
7.
Coutinho D, Mundi P, Marks L, Burke C, Ortiz M, Diolaiti D, et al.
Med
. 2022 Oct;
3(11):774-791.e7.
PMID: 36195086
Background: Malignant rhabdoid tumors (MRTs) and Wilms' tumors (WTs) are rare and aggressive renal tumors of infants and young children comprising ∼5% of all pediatric cancers. MRTs are among the...
8.
Bose S, Lee T, Choi S, Fazlollahi L, Rasiej M, Schwartz G, et al.
JCO Precis Oncol
. 2022 Jul;
6:e2100550.
PMID: 35820086
No abstract available.
9.
Gartrell R, Enzler T, Kim P, Fullerton B, Fazlollahi L, Chen A, et al.
Oncoimmunology
. 2022 May;
11(1):2066767.
PMID: 35558160
Patients with pancreatic ductal adenocarcinoma (PDAC) have a grim prognosis despite complete surgical resection and intense systemic therapies. While immunotherapies have been beneficial with many different types of solid tumors,...
10.
Jurkiewicz M, Cimic A, Murty V, Kuo J, Hsiao S, Fazlollahi L, et al.
Diagn Cytopathol
. 2020 Oct;
49(4):E146-E151.
PMID: 33085842
Thyroid cancer is the most common endocrine malignancy. Approximately 70% of cases of papillary thyroid carcinoma and 50% of poorly differentiated and anaplastic thyroid carcinoma harbor well-characterized driver mutations and...